A High Incidence of Metabolic Syndrome Traits in Mexicans Points at Obesity-Related Metabolic Dysfunction
Open Access
- 1 March 2021
- journal article
- research article
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 14, 1073-1082
Abstract
Introduction: Metabolic Syndrome (MS) is a construct relating to a series of metabolic dysfunctions attributable to insulin resistance and obesity. Here, we estimate the incidence of MS according to their individual components using a Mexican open-population cohort. Methods: We evaluated data of 6144 Mexicans amongst whom 3340 did not have MS either by IDF or ATP-III definitions using data from an open-population cohort. We estimated the incidence of MS and each of its traits after a median follow-up of 2.24 (IQR 2.05– 2.58) years and evaluated risk factors for MS incidence and each of its traits. We also explored individuals without any MS trait to evaluate trait and MS incidence after follow-up. Results: We observed a high incidence of MS-IDF (115.11 cases per 1000 person-years, 95% CI 107.76– 122.47), followed by MS-ATP-III (75.77 cases per 1000 person-years, 95% CI). The MS traits with the highest incidence were low HDL-C and abdominal obesity, which was consistent for subjects without MS and those without any MS trait. When assessing predictors of MS incidence, obesity, insulin resistance, and increased apolipoprotein B levels predicted MS incidence. Weight loss > 5% of body weight and physical activity were the main protective factors. Obesity was a main determinant for incident MS traits in our population, with weight loss being also a protective factor for most MS traits. Conclusion: We observed a high incidence of MS in apparently healthy Mexican adults. Low HDL-C and abdominal obesity were the most frequent incident MS traits, with obesity being the main determinant of its incidence.Keywords
This publication has 33 references indexed in Scilit:
- Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulnessJournal of Diabetes Investigation, 2013
- Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policyGlobalization and Health, 2013
- Insulin Resistance: Metabolic Mechanisms and Consequences in the HeartArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Adipose tissue dysfunction in obesity, diabetes, and vascular diseasesEuropean Heart Journal, 2008
- Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC studyInternational Journal of Obesity, 2008
- Apolipoprotein B is associated with metabolic syndrome in Chinese families with familial combined hyperlipidemia, familial hypertriglyceridemia and familial hypercholesterolemiaInternational Journal of Cardiology, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Familial Combined Hyperlipidemia in MexicansArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- High prevalence of metabolic syndrome in MexicoArchives of Medical Research, 2004
- Apolipoprotein B and A-I distribution in Mexican urban adults: Results of a nationwide surveyMetabolism, 2002